Notice: ASA extends its thoughts and condolences to those affected by the disaster in Oklahoma. Donations to help aid this relief can be made through the American Red Cross website.

>

WEBINARS

RSS
>

MEETINGS / EVENTS

RSS
>

FDA MEDWATCH ALERTS

RSS

June 13, 2013

Symbios GOPump and GOBlock Kits: Class 1 Recall - Potential for Excessive High Flow Rates

Summary:

Symbios GOPump and GOBlock Kits Class 1 Recall

June 11, 2013

Vecuronium Bromide For Injection by Sagent Pharmaceuticals, Inc.: Recall - Elevated Impurity Result Detected

Summary:

Vecuronium Bromide For Injection by Sagent Pharmaceuticals Inc

June 10, 2013

Main Street Family Pharmacy in Tennessee: FDA Alerts Health Care Providers of Adverse Reactions Associated with Steroid Injections

Summary:

Main Street Family Pharmacy in Tennessee FDA Alerts Health Care Providers

>

ASA FEATURED PRODUCT

Add this product to your shopping cart

Anesthesiology Continuing Education (ACE) Program

SKU: 30702-13CE

... Read more »

Single Copies, Member Price: $360

California Court of Appeals Sets Date for Oral Arguments in CSA and CMA v. Schwarzenegger

Thursday, December 22, 2011

The California Court of Appeals, 1st Appellate District, Division Four has set the date of January 10, 2012 at 1 p.m. for oral arguments in the appeal of California Society of Anesthesiologists (CSA) and California Medical Association (CMA) v. Schwarzenegger.  In October, the American Medical Association (AMA) and the American Society of Anesthesiologists (ASA) filed an amicus brief on behalf of the appellants, CSA and CMA, which focused on the grave consequences of Governor Arnold Schwarzenegger’s (R-CA) decision to opt-out of the federal requirement for physician supervision of nurse anesthetists, including the performance of interventional pain management procedures by nurse anesthetists.

« Back to Washington Alerts